Best Peptide for Anti-Aging
Epithalon, GHK-Cu, Humanin, MOTS-c & More — Ranked by Longevity Evidence (2026)
Anti-aging peptides span two broad categories: compounds with direct human evidence of telomere lengthening, cellular renewal, or immune restoration (Epithalon, GHK-Cu, Thymosin Alpha-1), and preclinical mitochondrial peptides with compelling animal longevity data (Humanin, MOTS-c). None are FDA-approved for longevity. This guide ranks them by depth of human evidence so you can build an informed protocol — and track every dose in Shotlee.
Top Anti-Aging Peptides — Ranked by Evidence
| Peptide / Compound | Mechanism | Best Human Evidence | Status | Evidence Level |
|---|---|---|---|---|
| Thymosin Alpha-1 | T-cell maturation, NK cell activation, immune aging reversal | Approved in 35+ countries for hepatitis and cancer immunotherapy | Approved (Zadaxin); off-label longevity | ⭐⭐⭐⭐⭐ |
| GHK-Cu | Copper tripeptide — collagen/elastin synthesis, 1,000+ gene activations | Multiple skin aging RCTs; broad regenerative data | Cosmetic ingredient / research peptide | ⭐⭐⭐⭐ |
| Epithalon | Telomerase activation, telomere lengthening, melatonin regulation | Phase 2: telomere lengthening in elderly subjects | Research peptide | ⭐⭐⭐⭐ |
| NAD+ (NMN/NR) | Sirtuin activation, mitochondrial biogenesis (not a peptide) | Multiple Phase 2 RCTs confirming NAD+ repletion | Dietary supplement | ⭐⭐⭐ |
| Rapamycin (mTOR inhibitor) | mTOR inhibition, autophagy induction (not a peptide) | ITP: lifespan extension in mice; geroscience trials ongoing | Approved (immunosuppressant); off-label longevity | ⭐⭐⭐ |
| BPC-157 | Angiogenesis, tissue regeneration, GI mucosal protection | Animal studies; limited human case data | Research only | ⭐⭐ |
| MOTS-c | Mitochondrial AMPK activation, metabolic regulation | Phase 1 safety trial; strong animal longevity data | Early clinical / research | ⭐⭐ |
| Humanin | Mitochondrial peptide — neuroprotection, apoptosis inhibition | Observational: lower levels in Alzheimer's patients | Research only | ⭐⭐ |
Evidence level reflects depth of human clinical trial data. Animal longevity data, however compelling, does not equal human clinical evidence. [1, 2, 3]
Top Anti-Aging Picks Explained
Epithalon (Epitalon)
GHK-Cu (Copper Tripeptide-1)
Thymosin Alpha-1 (TA-1)
Humanin
MOTS-c
NAD+ Precursors (NMN / NR)
How to Choose the Right Anti-Aging Peptide
For most people entering the longevity peptide space, the evidence-based starting stack is: Epithalon (telomere maintenance, 1–2 courses per year), GHK-Cu (topical for skin, systemic if injecting), and Thymosin Alpha-1 (immune aging). This combination addresses three independent aging pathways — telomere biology, regenerative signalling, and immunosenescence — and has the strongest human evidence among research peptides.
MOTS-c and Humanin are compelling additions if your focus is metabolic aging or neurodegeneration risk reduction. Both remain at early clinical stages for human longevity specifically. If you are already using metformin or rapamycin, adding MOTS-c may be partially redundant on the AMPK pathway and should be discussed with your physician.
Rapamycin and NAD+ precursors are the best-studied longevity interventions overall — neither is a peptide, but both are commonly combined with peptide protocols in longevity clinics. Work with a longevity medicine physician before combining multiple pathway interventions. Track all compounds in Shotlee to build a personal response dataset over time.
Track Your Longevity Protocol in Shotlee
Log every peptide course, dose, and cycle in Shotlee. Track biomarkers like telomere length results, inflammatory markers (CRP, IL-6), and metabolic panels over time to measure your personal anti-aging protocol response.
How to Track Your Anti-Aging Protocol in Shotlee
Establish a baseline: record starting biomarkers — CRP, telomere length test (if available), NAD+ levels, fasting insulin, and HbA1c — before your first peptide course
Log each peptide administration with compound name, dose, injection site, and date — essential for polypharmacy longevity stacks where timing between courses matters
Track Epithalon courses as separate protocol blocks (typically 10-day courses) to see course vs. washout patterns over time
Record subjective markers weekly: sleep quality, cognitive clarity, energy levels, and skin appearance — these often shift before lab markers do
Repeat biomarker panels every 6 months and compare to Shotlee baseline entries to quantify your protocol's measurable impact
Frequently Asked Questions
Epithalon has the most direct human evidence for telomere lengthening. GHK-Cu has the broadest regenerative evidence base across skin, tissue repair, and gene expression. Thymosin Alpha-1 has the strongest clinical approval record for immune aging. Most longevity protocols combine at least two of these three compounds.
Phase 2 research by the St. Petersburg Institute of Bioregulation showed telomere lengthening in elderly subjects receiving Epithalon vs. controls. The sample sizes are modest by drug trial standards, but it is currently the most direct human telomere-lengthening peptide evidence available. Track your Epithalon courses alongside telomere testing to build your own data.
Both activate AMPK, the master metabolic regulator. Metformin does so primarily via mitochondrial complex I inhibition. MOTS-c is a mitochondrially-encoded peptide that activates AMPK more directly and also has nucleus-targeting effects on gene expression under metabolic stress. Animal data suggests additive effects, but human combination data does not yet exist.
Yes — they act on distinct pathways (telomerase activation vs. copper-dependent gene regulation and regeneration) so they are not redundant. Many longevity practitioners run Epithalon 1–2x per year and use GHK-Cu continuously topically or in periodic injection courses between Epithalon cycles.
Rapamycin requires a prescription in all major jurisdictions and requires physician supervision for off-label longevity use. Side effects at low intermittent doses (1–6 mg weekly) appear mild in published case series, but drug interactions and immune suppression risk are real. Never use rapamycin without medical oversight.
References
- [1]Clinical TrialKhavinson VK, et al. "Epithalon peptide induces telomerase activity and telomere elongation in human somatic cells." Bulletin of Experimental Biology and Medicine. 2003;135(6):590-592.
- [2]ReviewPickart L, Margolina A. "Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data." Int J Mol Sci. 2018;19(7):1987.
- [3]ReviewLee C, et al. "MOTS-c: A novel mitochondrial-derived peptide regulating muscle and fat metabolism." Free Radic Biol Med. 2015;84:182-187.
Track Your Anti-Aging Protocol in Shotlee
Log every peptide course, biomarker result, and subjective change. Build the personal longevity dataset that shows you what is actually working.
🚀 Use Shotlee for Free